Member Info for Yorkshirepragma

Https://investors.apogeetherapeutics.com/news-releases/news-release-details/abbvie-acquire-apogee-therapeutics-deepening-immunology

The global salivary gland cancer treatment market is valued at roughly $1.78 billion and is projected to reach $3.27 billion by 2032, driven by rising head and neck cancer incidences and targeted therapy R&D. While surgery remains the primary treatment, chemotherapy is increasingly used for advanced or recurrent cases

I do suspect when it arrives we’ll be pleasantly surprised. I do hope so it’s a difficult treatment.

STS !! Apologies that’s the terminology ..

Prev STCarcinoma

It’s a b****r to treat , recurs ,?-and the PFS figures to date are more than ‘ hopefully’

Predict early acceptance .. and great potential .

A retired pharma bod …

An example of BP early engage e t eventually leading to purchase at inflexion point.

This will likely be similar to Av.’ Engaged in commercial discussions’ means something different in pharma speak

Imho

Https://apogeetherapeutics.com/pipeline

Https://www.biospace.com/drug-development/biogen-makes-up-to-1b-immuno-play-with-raythera-takeover

Https://www.bloomberg.com/news/articles/2026-06-09/gsk-to-buy-nuvalent-for-10-6-billion-to-expand-in-cancer-drugs?embedded-checkout=true

Drugs .All in development …

Https://www.biopharmadive.com/news/asco-2026-daraxonrasib-ivonescimab-proteus-erleada-results/821622/

With DCR of 92% in a rare cancer …a result of significance

AZ 5/4 fav.

Sankyo /AZ 1/1

*will not ignore a comparator mechanism with ‘ benefits’

https://www.astrazeneca.com/r-d/next-generation-therapeutics/antibody-drug-conjugate.html

Https://www.noah.bio/insight/dd45a3b4-8399-4563-b0a4-e545592f776f

Https://www.databridgemarketresearch.com/reports/global-salivary-gland-cancer-treatment-market?srsltid=AfmBOopuDJlblXlX-fKl6jv_4wnpZoCWwu8U9wbDVDDJzWJjso8gtXX_

Https://www.biopharmadive.com/news/lilly-kelonia-acquire-in-vivo-cell-therapy-multiple-myeloma/817953/

That’s M& A

Https://www.biopharmadive.com/news/biotech-pharma-deals-merger-acquisitions-tracker/604262/

Thanks for this analysis

Pancreatic such a poor responder too . Bodes well